Improving Transparency to Lower Drug Costs Act of 2021
Summary
Improving Transparency to Lower Drug Costs Act of 2021 This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jun 2021
Committee Review
Floor Vote
President
Introduced Jun 1, 2021
Last action Jun 2, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
3
Jun 2, 2021
Committee
Referred to the Subcommittee on Health.
lower
Jun 1, 2021
Committee
Referred to the Subcommittee on Health.
lower
Jun 1, 2021
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jun 1, 2021
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Abigail Davis Spanberger
DDemocratic
Co
Jodey C. Arrington
RRepublican
Co
Susan Wild
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 3682
Scope: US
Hi! I can help you understand HR 3682. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline